These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 23995067)

  • 1. Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.
    Flavahan WA; Wu Q; Hitomi M; Rahim N; Kim Y; Sloan AE; Weil RJ; Nakano I; Sarkaria JN; Stringer BW; Day BW; Li M; Lathia JD; Rich JN; Hjelmeland AB
    Nat Neurosci; 2013 Oct; 16(10):1373-82. PubMed ID: 23995067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Starvation favors glioma stem cells.
    Ilkhanizadeh S; Weiss WA
    Nat Neurosci; 2013 Oct; 16(10):1359-61. PubMed ID: 24067285
    [No Abstract]   [Full Text] [Related]  

  • 3. A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1.
    Libby CJ; Gc S; Benavides GA; Fisher JL; Williford SE; Zhang S; Tran AN; Gordon ER; Jones AB; Tuy K; Flavahan W; Gordillo J; Long A; Cooper SJ; Lasseigne BN; Augelli-Szafran CE; Darley-Usmar V; Hjelmeland AB
    Cell Adh Migr; 2021 Dec; 15(1):101-115. PubMed ID: 33843470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose Transporter 3 is Essential for the Survival of Breast Cancer Cells in the Brain.
    Kuo MH; Chang WW; Yeh BW; Chu YS; Lee YC; Lee HT
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment.
    Zhang HL; Wang MD; Zhou X; Qin CJ; Fu GB; Tang L; Wu H; Huang S; Zhao LH; Zeng M; Liu J; Cao D; Guo LN; Wang HY; Yan HX; Liu J
    Cancer Lett; 2017 Mar; 388():1-11. PubMed ID: 27894955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
    Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
    J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of murine xenograft models of brain tumors from primary human tissue for in vivo analysis of the brain tumor-initiating cell.
    Qazi M; Mann A; van Ommeren R; Venugopal C; McFarlane N; Vora P; Singh SK
    Methods Mol Biol; 2014; 1210():37-49. PubMed ID: 25173159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Compounds That Decrease Glioblastoma Growth and Glucose Uptake in Vitro.
    Landis CJ; Zhang S; Benavides GA; Scott SE; Li Y; Redmann M; Tran AN; Otamias A; Darley-Usmar V; Napierala M; Zhang J; Augelli-Szafran CE; Zhang W; Hjelmeland AB
    ACS Chem Biol; 2018 Aug; 13(8):2048-2057. PubMed ID: 29905460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.
    Zemp FJ; Lun X; McKenzie BA; Zhou H; Maxwell L; Sun B; Kelly JJ; Stechishin O; Luchman A; Weiss S; Cairncross JG; Hamilton MG; Rabinovich BA; Rahman MM; Mohamed MR; Smallwood S; Senger DL; Bell J; McFadden G; Forsyth PA
    Neuro Oncol; 2013 Jul; 15(7):904-20. PubMed ID: 23585629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity.
    Sarkar S; Poon CC; Mirzaei R; Rawji KS; Hader W; Bose P; Kelly J; Dunn JF; Yong VW
    Sci Rep; 2018 Oct; 8(1):15286. PubMed ID: 30327548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose transporter 3 in neuronal glucose metabolism: Health and diseases.
    Peng W; Tan C; Mo L; Jiang J; Zhou W; Du J; Zhou X; Liu X; Chen L
    Metabolism; 2021 Oct; 123():154869. PubMed ID: 34425073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Patient-Derived Xenograft Model Using Brain Tumor Stem Cell Systems to Study Cancer.
    Chokshi C; Dhillon M; McFarlane N; Venugopal C; Singh SK
    Methods Mol Biol; 2016; 1458():231-45. PubMed ID: 27581026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells.
    Choi SA; Lee JY; Kwon SE; Wang KC; Phi JH; Choi JW; Jin X; Lim JY; Kim H; Kim SK
    PLoS One; 2015; 10(6):e0129292. PubMed ID: 26076490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells.
    Seliger C; Rauer L; Wüster AL; Moeckel S; Leidgens V; Jachnik B; Ammer LM; Heckscher S; Dettmer K; Riemenschneider MJ; Oefner PJ; Proescholdt M; Vollmann-Zwerenz A; Hau P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.
    Shibuya K; Okada M; Suzuki S; Seino M; Seino S; Takeda H; Kitanaka C
    Oncotarget; 2015 Jan; 6(2):651-61. PubMed ID: 25528771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53.
    Fukaya R; Ohta S; Yaguchi T; Matsuzaki Y; Sugihara E; Okano H; Saya H; Kawakami Y; Kawase T; Yoshida K; Toda M
    Cancer Res; 2016 May; 76(9):2813-23. PubMed ID: 26980763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
    Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
    Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.
    Yu D; Khan OF; Suvà ML; Dong B; Panek WK; Xiao T; Wu M; Han Y; Ahmed AU; Balyasnikova IV; Zhang HF; Sun C; Langer R; Anderson DG; Lesniak MS
    Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6147-E6156. PubMed ID: 28696296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.